Prediction Models for Elevated Cardiac Biomarkers from Previous Risk Factors and During the COVID-19 Pandemic in Residents of Trujillo City, Peru

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2024 Nov 27

PMID 39594168

Authors

Joao Caballero-Vidal

Jorge Luis Diaz-Ortega

Irma Luz Yupari-Azabache

Luz Angelica Castro-Caracholi

Juan M Alva Sevilla

Affiliations

Soon will be listed here.

Abstract

Cardiac troponin serum concentration is a marker of myocardial injury, but NT-pro BNP is a marker of myocardial insufficiency. The purpose of this study was to determine binary logistic regression models to verify the possible association of cardiovascular risk indicators, pre-pandemic history, the number of times participants were infected with SARS-CoV-2, and vaccination against these biomarkers. A total of 281 residents of Trujillo city (Peru) participated between September and December 2023. We found a high prevalence of abdominal obesity of 55.2%; glycemia > 100 m/dL in 53%; hypercholesterolemia in 49.8%; low HDL in 71.9%; and LDL > 100 mg/dL in 78.6%. A total of 97.5% were vaccinated against COVID-19, and 92.2% had three or more doses. Also, 2.5% had cTnI > 0.05 ng/mL, and 3.3% had NT-proBNP > 125 pg/mL. The number of COVID-19 infections versus cTnI > 0.05 ng/mL presented an OR = 3.513 ( = 0.003), while for NT-proBNP > 125 pg/mL, the number of comorbidities presented an OR = 2.185 ( = 0.025) and LDL an OR = 0.209 ( = 0.025). A regression model was obtained in which there is an association between a higher number of COVID-19 infections and elevated cTnI values and a model implying an association of the number of comorbidities and LDL with the NT-proBNP level in a direct and inverse manner, respectively. Both models contribute to the prevention of cardiac damage.

References

Martinez Perez J, Perez Martin P . [Logistic regression]. Semergen. 2023; 50(1):102086. DOI: 10.1016/j.semerg.2023.102086. View

Welsh P, Preiss D, Shah A, McAllister D, Briggs A, Boachie C . Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort. Clin Chem. 2018; 64(11):1607-1616. PMC: 6398571. DOI: 10.1373/clinchem.2018.292086. View

Odum E, Young E . Elevated cardiac troponin I, creatine kinase and myoglobin and their relationship with cardiovascular risk factors in patients with type 2 diabetes. Diabetes Metab Syndr. 2017; 12(2):141-145. DOI: 10.1016/j.dsx.2017.12.001. View

Lyngbakken M, Kimenai D, Hveem K, Dalen H, Rosjo H, Omland T . Patterns of Cardiac Troponin I Concentrations as Risk Predictors of Cardiovascular Disease and Death: The Trøndelag Health Study. Am J Med. 2023; 136(9):902-909.e4. DOI: 10.1016/j.amjmed.2023.05.009. View

Sbaraini da Silva M, Lazo M, Daya N, Tang O, Schaan B, Ballantyne C . Six-year changes in N-terminal pro-brain natriuretic peptide and changes in weight and risk of obesity. Obesity (Silver Spring). 2021; 29(7):1215-1222. PMC: 8231730. DOI: 10.1002/oby.23181. View

Sanchez O, Duprez D, Bahrami H, Daniels L, Folsom A, Lima J . The associations between metabolic variables and NT-proBNP are blunted at pathological ranges: the Multi-Ethnic Study of Atherosclerosis. Metabolism. 2014; 63(4):475-83. PMC: 3965618. DOI: 10.1016/j.metabol.2013.11.017. View

Keefe J, Avadhanula V, Nicholson E, Devaraj S, Piedra P, Bozkurt B . Abnormalities in cardiac and inflammatory biomarkers in ambulatory subjects after COVID-19 infection. Int J Cardiol Heart Vasc. 2022; 43:101144. PMC: 9613792. DOI: 10.1016/j.ijcha.2022.101144. View

Raman B, Bluemke D, Luscher T, Neubauer S . Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022; 43(11):1157-1172. PMC: 8903393. DOI: 10.1093/eurheartj/ehac031. View

Fazlollahi A, Zahmatyar M, Noori M, Nejadghaderi S, Sullman M, Shekarriz-Foumani R . Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series. Rev Med Virol. 2021; 32(4):e2318. DOI: 10.1002/rmv.2318. View

10.

Juraschek S, Kovell L, Appel L, Miller 3rd E, Sacks F, Christenson R . Associations Between Dietary Patterns and Subclinical Cardiac Injury: An Observational Analysis From the DASH Trial. Ann Intern Med. 2020; 172(12):786-794. PMC: 7388686. DOI: 10.7326/M20-0336. View

11.

Tanaka A, Yoshida H, Kawaguchi A, Oyama J, Kotooka N, Toyoda S . N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study. Sci Rep. 2017; 7(1):5810. PMC: 5517578. DOI: 10.1038/s41598-017-06090-6. View

12.

Millan J, Hernandez-Mijares A, Ascaso J, Blasco M, Brea A, Diaz A . [The real measurement of non-HDL-cholesterol: Atherogenic cholesterol]. Clin Investig Arterioscler. 2016; 28(6):265-270. DOI: 10.1016/j.arteri.2016.05.002. View

13.

Zhu W, Chen L, Dai H, Chen J, Chen Y, Fang L . Correlation between B type natriuretic peptide and metabolic risk factors. Arch Med Sci. 2016; 12(2):334-40. PMC: 4848355. DOI: 10.5114/aoms.2015.57001. View

14.

Spannella F, Giulietti F, Cocci G, Landi L, Borioni E, Lombardi F . N-terminal pro B-Type natriuretic peptide is inversely correlated with low density lipoprotein cholesterol in the very elderly. Nutr Metab Cardiovasc Dis. 2018; 28(6):629-635. DOI: 10.1016/j.numecd.2018.02.013. View

15.

Barreiro-Perez M, Pastor Pueyo P, Raposeiras-Roubin S, Montero Corominas D, Uribarri A, Eiros Bachiller R . Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management. Rev Esp Cardiol (Engl Ed). 2023; 76(7):555-563. PMC: 10008093. DOI: 10.1016/j.rec.2023.01.011. View

16.

Lee D, Gardner R, Porter D, Louis C, Ahmed N, Jensen M . Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014; 124(2):188-95. PMC: 4093680. DOI: 10.1182/blood-2014-05-552729. View

17.

Langa L, Sallent L, Diez S . . FMC. 2021; 28(3):167-173. PMC: 7984870. DOI: 10.1016/j.fmc.2021.01.005. View

18.

Zhang S, Wang Q, Cui Y, Wu W, Zhao Q, Xu Y . High-sensitivity cardiac troponin T in geriatric inpatients. Arch Gerontol Geriatr. 2016; 65:111-5. DOI: 10.1016/j.archger.2016.03.010. View

19.

Lyngbakken M, Rosjo H, Holmen O, Dalen H, Hveem K, Omland T . Temporal Changes in Cardiac Troponin I Are Associated with Risk of Cardiovascular Events in the General Population: The Nord-Trøndelag Health Study. Clin Chem. 2019; 65(7):871-881. DOI: 10.1373/clinchem.2018.301069. View

20.

Perez-Jimenez F, Pascual V, Meco J, Perez Martinez P, Delgado Lista J, Domenech M . Document of recommendations of the SEA 2018. Lifestyle in cardiovascular prevention. Clin Investig Arterioscler. 2018; 30(6):280-310. DOI: 10.1016/j.arteri.2018.06.005. View